Guardant Health
GH
#3559
Rank
A$4.62 B
Marketcap
$37.63
Share price
-1.18%
Change (1 day)
-11.90%
Change (1 year)
Guardant Health is an American company developing blood tests for early detection in high-risk populations and recurrence monitoring in cancer survivors.

Guardant Health (GH) - Total liabilities

Total liabilities on the balance sheet as of June 2024 : A$2.41 B

According to Guardant Health 's latest financial reports the company's total liabilities are A$2.41 B. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Guardant Health - Total liabilities on balance sheet (from 2017 to 2024)

Total liabilities by year

Year Total liabilities Change
2023-12-31A$2.38 B4.91%
2022-12-31A$2.27 B6.18%
2021-12-31A$2.14 B80.39%
2020-12-31A$1.18 B629.69%
2019-12-31A$0.16 B83.87%
2018-12-31A$88.61 M101.52%
2017-12-31A$43.97 M-14.02%
2016-12-31A$51.14 M

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
A$1.02 B-57.76%๐Ÿ‡บ๐Ÿ‡ธ USA
A$2.10 B-12.80%๐Ÿ‡บ๐Ÿ‡ธ USA